Related Experiment Video
Updated: Aug 15, 2026
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
The Italian quality control scheme for crossmatching procedures and HLA sera screening: the 2002 pilot study
Raffaele Conca1, Loredana Praticò-Barbato, Anna Maria Dall'Omo
1Department of Genetics, Biology, and Biochemistry, University of Torino, Turin, Italy. raffa.conca@libero.it
Context:
The first national quality control (QC) program of histocompatibility serum testing was performed in Italy in 2002.
Objective:
To monitor the performance of HLA typing laboratories while meeting the accreditation requirements of the European Federation for Immunogenetics (EFI), which require HLA typing laboratories to participate in external QC of their crossmatch and antibody analyses.
Design:
The Turin Transplant Immunology Service was asked to organize a QC survey of 17 HLA typing laboratories in Italy. Each laboratory received 12 serum specimens and 6 blood samples and was required to perform 36 crossmatches and 12 serum antibody specificity determinations.
Settings:
Data of participating centers were compared to establish whether EFI requirements were satisfied.
Results:
In crossmatch analysis, the results of 32 of 36 crossmatches reached the 75% consensus target, with all the participating laboratories meeting the standards of the EFI. In antibody analysis, only 7 of 17 laboratories met the EFI standards.
Conclusion:
The first Italian QC program shows that the participating laboratories obtained consistent results in crossmatching, whereas the results were less satisfactory in the determination of serum antibody specificity, where consensus was reached only with monospecific sera and antibody-negative samples.
